|
FAM102B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.048800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.077200E-01 |
| Normal-vs-Stage2 |
1.247030E-01 |
| Normal-vs-Stage3 |
4.510000E-01 |
| Normal-vs-Stage4 |
2.783800E-01 |
| Stage1-vs-Stage2 |
4.006400E-02 |
| Stage1-vs-Stage3 |
9.393600E-01 |
| Stage1-vs-Stage4 |
5.949200E-01 |
| Stage2-vs-Stage3 |
4.528000E-02 |
| Stage2-vs-Stage4 |
2.911900E-02 |
| Stage3-vs-Stage4 |
6.554200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.269200E-01 |
| Normal-vs-AfricanAmerican |
2.157600E-01 |
| Normal-vs-Asian |
1.727960E-01 |
| Caucasian-vs-AfricanAmerican |
2.631600E-01 |
| Caucasian-vs-Asian |
2.784400E-01 |
| AfricanAmerican-vs-Asian |
8.223800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.129400E-01 |
| Normal-vs-Female |
5.153400E-01 |
| Male-vs-Female |
9.596600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.558600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.927400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.478000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.287000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.814000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.432560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.005400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.393600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.506000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.618400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.237400E-01 |
| Classical-VS-Follicular |
3.42799999997201E-06 |
| Classical-VS-Other |
4.808800E-01 |
| Classical-VS-Normal |
5.088000E-02 |
| Tall-VS-Follicular |
1.975760E-03 |
| Tall-VS-Other |
4.075600E-01 |
| Tall-VS-Normal |
1.540190E-01 |
| Follicular-VS-Other |
4.642600E-01 |
| Follicular-VS-Normal |
2.226500E-02 |
| Other-VS-Normal |
8.790000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.727800E-01 |
| Normal-vs-N1 |
6.832800E-01 |
| N0-vs-N1 |
4.381200E-01 |
|
|
